✦ LIBER ✦

A Question of Duration: Do Patients with Early-Stage Breast Cancer Need More Than Five Years of Adjuvant Endocrine Therapy?

✍ Scribed by Susan Burdette-Radoux; Hyman B. Muss

Book ID: 115075847
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 106 KB
Volume: 9
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2009.s.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of tumor progesterone recepto

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer : A decision analysis

✍ Rinaa S. Punglia; Karen M. Kuntz; Eric P. Winer; Jane C. Weeks; Harold J. Burste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

Five versus more than five years of tamo

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors: Fisher B, Dignam J, Bryant J, DeCillis A, Wickeham L, Wolmark N, Constantino J, Redmond C, Fisher ER, Bowman DM, Deschênes L, Dimitrov NV, Margolese RG, Robidoux R, Shibata H, Terz A, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickney HL J Natl Cancer Inst 1996:88:1529-42

📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 115 KB